samarium has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franke, WG; Hebrank, H; Saccavini, JC; Scharl, A; Scheidhauer, K; Schicha, H; Schomäcker, K; Shukla, SK | 1 |
| Budd, RS; Martin, JJ; Sandeman, TF | 1 |
2 other study(ies) available for samarium and Carcinoma, Anaplastic
| Article | Year |
|---|---|
[Influence on extratumoral organ activities of tumor-affinity samarium-153 preparations].
Topics: Animals; Carcinoma; Chelating Agents; Male; Mice; Mice, Inbred DBA; Nitrilotriacetic Acid; Organophosphorus Compounds; Radioisotopes; Radionuclide Imaging; Samarium; Tissue Distribution; Yttrium | 1997 |
Samarium-153-labelled EDTMP for bone metastases from cancer of the prostate.
Topics: Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Carcinoma; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Remission Induction; Samarium; Survival Rate; Thrombocytopenia | 1992 |